Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Abbott enters global agreement for novel JAK1 inhibitor

Feb. 29, 2012

Samsung Biologics and Biogen Idec form joint venture

Feb. 29, 2012

Lundbeck acquires remaining rights to ischemic stroke treatment candidate

Feb. 29, 2012

Antisense Therapeutics to form joint venture for development of ATL-1102

Feb. 29, 2012

Selventa enters new collaboration

Feb. 29, 2012

Biodesix enters new collaboration

Feb. 28, 2012

Merck & Co. licenses Protein Sciences technology for vaccine research

Feb. 28, 2012

MorphoSys announces signing of protein engineering agreement

Feb. 28, 2012

Galen acquires chemotherapy agent from Gilead

Feb. 27, 2012

Angiochem and GSK launch new collaboration

Feb. 27, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....